All Clinical Trials:
Oncology Clinical Trial: Gastrointestinal Microbe Population Changes in Newly Diagnosed Pediatric Pre-B Acute Lymphoblastic Leukemia Patients
Clinical Trial | Biology/Genomics, Leukemia/Lymphoma | Contact (714) 509-8646
Oncology Clinical Trial: Glembatumumab Vedotin in Treating Patients With Recurrent or Refractory Osteosarcoma
Clinical Trial Protocol # AOST1521 | Recurrent/Refractory Cancer, solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: Ketogenic Diet as a Complementary Metabolic Therapy in Pediatric Recurrent/Refractory Solid Tumors including Central Nervous System (CNS) Tumors
Clinical Trial | Brain Tumor/Central Nervous System/Neuro-Oncology, Recurrent/Refractory Cancer, Solid Tumors, Supportive Care | Contact (714) 509-8646
Oncology Clinical Trial: Long-Term Follow-Up of Patients Who Have Participated in Children’s Oncology Group Studies
Clinical Trial Protocol # ALTE05N1 | Survivorship | Contact (714) 509-8646
Oncology Clinical Trial: Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma
Clinical Trial Protocol # ADVL1522 | Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma
Clinical Trial Protocol # ACNS0831 | Brain Tumor/Central Nervous System/Neuro-Oncology | Contact (714) 509-8646
Oncology Clinical Trial: Molecular Profiles of Refractory and Recurrent Childhood, Adolescent, and Young Adult Cancers
Clinical Trial | Adolescents and Young Adults, Biology/Genomics, Brain Tumor/Central Nervous System/Neuro-Oncology, Leukemia/Lymphoma, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: Neuropsychological and Behavioral Testing in Younger Patients With Cancer
Clinical Trial Protocol # ALTE07C1 | Survivorship | Contact (714) 509-8646
Oncology Clinical Trial: Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas
Clinical Trial Protocol # ADVL1412 | Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: Pazopanib Paediatric Phase II Trial Children’s Oncology Group (COG) in Solid Tumors
Clinical Trial Protocol # ADVL1322 | Adolescents and Young Adults, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: Project – Every Child for Younger Patients With Cancer
Clinical Trial Protocol # APEC14B1 | Biology/Genomics, Registry | Contact (714) 509-8646
Oncology Clinical Trial: Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery
Clinical Trial Protocol # ARST1321 | Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
Clinical Trial Protocol # ANBL1232 | Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
Clinical Trial Protocol #: AAML1531 | Leukemia/Lymphoma | Contact (714) 509-8646
Oncology Clinical Trial: Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma
Clinical Trial Protocol # AALL0932 | Leukemia/Lymphoma | Contact (714) 509-8646
Oncology Clinical Trial: Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Clinical Trial Protocol # AALL08B1 | Biology/Genomics, Leukemia/Lymphoma | Contact (714) 509-8646
Oncology Clinical Trial: Study of a Tool for Advanced Care Planning in Young Adults Cancer and Other Life Threatening Illnesses
Clinical Trial | Adolescents and Young Adults, Recurrent/Refractory Cancer, Supportive Care, Survivorship | Contact (714) 509-8646
Oncology Clinical Trial: Study of Blood Samples From Newborns With Down Syndrome
Clinical Trial Protocol # AAML08B1 | Biology/Genomics, Leukemia/Lymphoma | Contact (714) 509-8646
Oncology Clinical Trial: Study of Kidney Tumors in Younger Patients
Clinical Trial Protocol # AREN03B2 | Biology/Genomics, Registry | Contact (714) 509-8646
Oncology Clinical Trial: Study of response of lymphomas and leukemias to standard chemotherapies in patients with Biallelic Mismatch Repair Deficiencies (BMMRD)
Clinical Trial | Biology/Genomics, Leukemia/Lymphoma | Contact (714) 509-8646
Oncology Clinical Trial: Study of Selinexor in Pediatric Solid Tumors
Clinical Trial Protocol # ADVL1414 | Brain Tumor/Central Nervous System/Neuro-Oncology, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
Oncology Clinical Trial: Treatment for Advanced B-Cell Lymphoma
Clinical Trial | Adolescents and Young Adults, Leukemia/Lymphoma, Recurrent/Refractory Cancer | Contact (714) 509-8646
Oncology Clinical Trial: Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia
Clinical Trial Protocol # AAML1331 | Leukemia/Lymphoma | Contact (714) 509-8646
Oncology Clinical Trial: Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy for Children, Adolescents, and Young Adults With Relapsed ALL
Clinical Trial Protocol #T2012-002 | Adolescents and Young Adults, Leukemia/Lymphoma, Recurrent/Refractory Cancer | Contact (714) 509-8646
Oncology Clinical Trial: WEE1 Inhibitor MK-1775 and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Clinical Trial Protocol # ADVL1312 | Adolescents and Young Adults, Brain Tumor/Central Nervous System/Neuro-Oncology, Recurrent/Refractory Cancer, Solid Tumors | Contact (714) 509-8646
